BeOne Medicines (ONC) Asset Utilization Ratio (2016 - 2026)

BeOne Medicines (ONC) has 11 years of Asset Utilization Ratio data on file, last reported at 0.69 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 3.44% year-over-year to 0.69 in Q1 2026; TTM through Mar 2026 was 0.69, a 3.44% decrease from a year earlier, with the FY2025 full-year figure at 0.76, up 16.54% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.69, up from 0.68 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for ONC reached as high as 0.75 in Q2 2025 and fell as low as 0.11 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.46 across 5 years, with a median of 0.48 in 2024.
• Across the five-year window, Asset Utilization Ratio retreated 29.87% in 2022 and soared 157.0% in 2023, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.23 in 2022, then jumped by 87.09% to 0.43 in 2023, then jumped by 49.41% to 0.65 in 2024, then climbed by 4.16% to 0.68 in 2025, then advanced by 1.51% to 0.69 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.69 in Q1 2026, 0.68 in Q4 2025, and 0.71 in Q3 2025.